The Extracellular Matrix Influences Ovarian Carcinoma Cells’ Sensitivity to Cisplatinum: A First Step towards Personalized Medicine

The development of personalized therapies for ovarian carcinoma patients is still hampered by several limitations, mainly the difficulty of predicting patients’ responses to chemotherapy in tumor cells isolated from peritoneal fluids. The main reason for the low predictive power of in vitro assays i...

Descripción completa

Detalles Bibliográficos
Autores principales: Balduit, Andrea, Agostinis, Chiara, Mangogna, Alessandro, Maggi, Veronica, Zito, Gabriella, Romano, Federico, Romano, Andrea, Ceccherini, Rita, Grassi, Gabriele, Bonin, Serena, Bonazza, Deborah, Zanconati, Fabrizio, Ricci, Giuseppe, Bulla, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281165/
https://www.ncbi.nlm.nih.gov/pubmed/32392708
http://dx.doi.org/10.3390/cancers12051175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281165/
https://www.ncbi.nlm.nih.gov/pubmed/32392708
http://dx.doi.org/10.3390/cancers12051175

Ejemplares similares